Reuters logo
BRIEF-Biophytis Announces ‍FAMHP Approval To Conduct Sara-Interest Phase 2B Study In Belgium​
December 4, 2017 / 7:09 AM / 15 days ago

BRIEF-Biophytis Announces ‍FAMHP Approval To Conduct Sara-Interest Phase 2B Study In Belgium​

Dec 4 (Reuters) - BIOPHYTIS SA:

* ‍FAMHP APPROVAL TO CONDUCT SARA-INTEREST PHASE 2B INTERVENTIONAL STUDY OF SARCONEOS IN SARCOPENIA IN BELGIUM​

* ‍FAMHP APPROVAL WILL ENABLE BIOPHYTIS TO INITIATE SARA-INTEREST PHASE 2B INTERVENTIONAL STUDY IN 3 CLINICAL CENTERS IN BELGIUM

* ‍NEXT STEPS WILL BE TO OBTAIN REGULATORY APPROVALS IN FRANCE AND IN ITALY, AND INCLUSION OF FIRST PATIENTS IN UNITED STATES AND IN EUROPE ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below